✦ LIBER ✦

Pemetrexed mit Cisplatin in der Erstlinientherapie des NSCLC

✍ Scribed by N.J. Dickgreber

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pemetrexed + cisplatin active in advance

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

9077 Phase 2 study of pemetrexed and cis

✍ Reck, M.; Ramlau, R.; VonPawel, J.; Antonio, B. San; Visseren-Grul, C.; Chouaki, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

PCN36 COST ANALYSIS, SAFETY, AND EFFICAC

✍ P. Davey; N. Rajan; Y. Kanivets; H. Barraclough; M. Orlando; A.J. Brnabic; B. Ha 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

A Cost-Effectiveness Analysis of Cisplat

✍ Bryden, P.A.; Kumar, G.; Winfree, K.B.; Boye, M.E.; Taipale, K.; Thompson, R.; B 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

1BA Phase III study of pemetrexed plus c

✍ C. Manegold; R. Digumarti; M. Zukin; F. de Marinis; A. Mellemgaard; D. Gandara; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Bevacizumab in der First-Line-Therapie d

✍ Norbert Hasenöhrl 📂 Article 📅 2007 🏛 Springer Vienna 🌐 German ⚖ 73 KB